Michael R. Costello, MD

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Exton
View 1 additional location
Make an appointmentCall 800-789-7366
Headshot of Michael R. Costello, MD
Penn Medicine Provider

About me

  • Medical Director. The Abramson Cancer Center West Chester

My education and training

  • Medical School: Penn State Milton S. Hershey Medical Center
  • Residency: Temple University Hospital
  • Fellowship: Temple University Hospital

Reviews

Average Rating

1213 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
exceptional visit. dr. costello was very knowledgeable. he was kind. he listened and explained things. i'm beyond grateful and appreciative of his medical care.
Anonymous
April 2026
friendly and informative
Anonymous
April 2026
dr. costello is very knowledgable and thorough. excellent doctor.
Anonymous
April 2026
very happy to see dr costello again to set up blood work, transfusions, and chemo

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Costello is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Cosstello MR, Meropol NJ, Denlinger CS, Engstrom PF, Wright JJ, Li T, McLaughlin S, Beard M, Cimildoro R, Cohen SJ. A phase II trial of the proteasome inhibitor bortezomib in patients with recurrent or metastatic adenocarcinoma of the bile duct or gallbladder (NCI #6135). , Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post Meeting Edition)., 27(155): 2009,e15605

Michael Costello Current Recommendations for Screening for Cervical Cancer , Temple University Hospital Morning Conference Series: 2006

Michael Costello Treatment of Thromboembolic Disease in Oncological Patients , Temple University Hospital Morning Conference Series: 2005

Michael Costello Methicillin Resistant Staph Aureus Infection in a 26 year old patient , Temple University Hospital Morning Conference Series: 2005